Product Details for ANDA 065386
PIPERACILLIN AND TAZOBACTAM (PIPERACILLIN SODIUM; TAZOBACTAM SODIUM)
EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL
Marketing Status: Discontinued
EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL
Marketing Status: Discontinued
EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL
Marketing Status: Discontinued
EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Proprietary Name: PIPERACILLIN AND TAZOBACTAM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A065386
Product Number: 001
Approval Date: Sep 15, 2009
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
PIPERACILLIN AND TAZOBACTAM (PIPERACILLIN SODIUM; TAZOBACTAM SODIUM)
Proprietary Name: PIPERACILLIN AND TAZOBACTAM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A065386
Product Number: 001
Approval Date: Sep 15, 2009
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Proprietary Name: PIPERACILLIN AND TAZOBACTAM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A065386
Product Number: 002
Approval Date: Sep 15, 2009
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
PIPERACILLIN AND TAZOBACTAM (PIPERACILLIN SODIUM; TAZOBACTAM SODIUM)
Proprietary Name: PIPERACILLIN AND TAZOBACTAM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A065386
Product Number: 002
Approval Date: Sep 15, 2009
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Proprietary Name: PIPERACILLIN AND TAZOBACTAM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A065386
Product Number: 003
Approval Date: Sep 15, 2009
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: PIPERACILLIN AND TAZOBACTAM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A065386
Product Number: 003
Approval Date: Sep 15, 2009
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information